학술논문
Efficacy and safety of tixagevimab-cilgavimab versus SARS-CoV-2 breakthrough infection in the hematological conditions
Document Type
Article
Author
Source
In: Cancer . (Cancer, 1 January 2024, 130(1):41-50)
Subject
Language
English
ISSN
10970142
0008543X
0008543X